Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,807 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combined therapeutic effects of adenoviral vector-mediated GLIPR1 gene therapy and radiotherapy in prostate and bladder cancer models.
Fujita T, Satoh T, Timme TL, Hirayama T, Zhu JX, Kusaka N, Naruishi K, Yang G, Goltsov A, Wang J, Vlachaki MT, Teh BS, Brian Butler E, Thompson TC. Fujita T, et al. Among authors: satoh t. Urol Oncol. 2014 Feb;32(2):92-100. doi: 10.1016/j.urolonc.2012.10.007. Epub 2013 Feb 20. Urol Oncol. 2014. PMID: 23433894 Free PMC article.
Prostate-specific antigen response and systemic T cell activation after in situ gene therapy in prostate cancer patients failing radiotherapy.
Miles BJ, Shalev M, Aguilar-Cordova E, Timme TL, Lee HM, Yang G, Adler HL, Kernen K, Pramudji CK, Satoh T, Gdor Y, Ren C, Ayala G, Wheeler TM, Butler EB, Kadmon D, Thompson TC. Miles BJ, et al. Among authors: satoh t. Hum Gene Ther. 2001 Nov 1;12(16):1955-67. doi: 10.1089/104303401753204535. Hum Gene Ther. 2001. PMID: 11686937 Clinical Trial.
In situ gene therapy for prostate cancer: immunomodulatory approaches.
Thompson TC, Timme TL, Ebara S, Satoh T, Yang G, Wang J, Miles BJ, Ayala G, Wheeler TM, Kadmon D. Thompson TC, et al. Among authors: satoh t. Expert Opin Biol Ther. 2001 May;1(3):481-95. doi: 10.1517/14712598.1.3.481. Expert Opin Biol Ther. 2001. PMID: 11727520 Review.
The role of caveolin-1 in androgen insensitive prostate cancer.
Mouraviev V, Li L, Tahir SA, Yang G, Timme TM, Goltsov A, Ren C, Satoh T, Wheeler TM, Ittmann MM, Miles BJ, Amato RJ, Kadmon D, Thompson TC. Mouraviev V, et al. Among authors: satoh t. J Urol. 2002 Oct;168(4 Pt 1):1589-96. doi: 10.1016/S0022-5347(05)64526-0. J Urol. 2002. PMID: 12352463 Review.
Therapeutic targets for metastatic prostate cancer.
Timme TL, Satoh T, Tahir SA, Wang H, Teh BS, Butler EB, Miles BJ, Amato RJ, Kadmon D, Thompson TC. Timme TL, et al. Among authors: satoh t. Curr Drug Targets. 2003 Apr;4(3):251-61. doi: 10.2174/1389450033491127. Curr Drug Targets. 2003. PMID: 12643475 Review.
Disruption of the caveolin-1 gene impairs renal calcium reabsorption and leads to hypercalciuria and urolithiasis.
Cao G, Yang G, Timme TL, Saika T, Truong LD, Satoh T, Goltsov A, Park SH, Men T, Kusaka N, Tian W, Ren C, Wang H, Kadmon D, Cai WW, Chinault AC, Boone TB, Bradley A, Thompson TC. Cao G, et al. Among authors: satoh t. Am J Pathol. 2003 Apr;162(4):1241-8. doi: 10.1016/S0002-9440(10)63920-X. Am J Pathol. 2003. PMID: 12651616 Free PMC article.
3,807 results